ES8307212A1 - Un procedimiento para la preparacion de derivados de acidos alcanoicos. - Google Patents

Un procedimiento para la preparacion de derivados de acidos alcanoicos.

Info

Publication number
ES8307212A1
ES8307212A1 ES513221A ES513221A ES8307212A1 ES 8307212 A1 ES8307212 A1 ES 8307212A1 ES 513221 A ES513221 A ES 513221A ES 513221 A ES513221 A ES 513221A ES 8307212 A1 ES8307212 A1 ES 8307212A1
Authority
ES
Spain
Prior art keywords
alkyl
unsubstituted
carbon atoms
aryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES513221A
Other languages
English (en)
Other versions
ES513221A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of ES513221A0 publication Critical patent/ES513221A0/es
Publication of ES8307212A1 publication Critical patent/ES8307212A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B45/00—Formation or introduction of functional groups containing sulfur
    • C07B45/04—Formation or introduction of functional groups containing sulfur of sulfonyl or sulfinyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C07D303/42—Acyclic compounds having a chain of seven or more carbon atoms, e.g. epoxidised fats
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/04—Seven-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5304—Acyclic saturated phosphine oxides or thioxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5325—Aromatic phosphine oxides or thioxides (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE ACIDOS ALCANOICOS, DE FORMULA (I), EN LA QUE Y, R Y R PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN CLORURO DE SULFENILO DE FORMULA R SCL, EN LAS QUE R Y R W TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA BASE, TAL COMO UNA AMINA TERCIARIA, A UNA TEMPERATURA ENTRE -60 C Y 60 C; EL COMPUESTO OBTENIDO SE SEPARA EN FORMA DE LACTONA O SE HIDROLIZA AL ACIDO LIBRE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE TRASTORNOS ALERGICOS/INFLAMATORIOS DEBIDOS A LA SRS-A.
ES513221A 1981-06-18 1982-06-17 Un procedimiento para la preparacion de derivados de acidos alcanoicos. Expired ES8307212A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8118720 1981-06-18
GB8213211 1982-05-07

Publications (2)

Publication Number Publication Date
ES513221A0 ES513221A0 (es) 1983-07-01
ES8307212A1 true ES8307212A1 (es) 1983-07-01

Family

ID=26279835

Family Applications (3)

Application Number Title Priority Date Filing Date
ES513221A Expired ES8307212A1 (es) 1981-06-18 1982-06-17 Un procedimiento para la preparacion de derivados de acidos alcanoicos.
ES520671A Granted ES520671A0 (es) 1981-06-18 1983-03-16 Un procedimiento para la preparacion de derivados de acidos alcanoicos.
ES520670A Expired ES8404307A1 (es) 1981-06-18 1983-03-16 Un procedimiento para la preparacion de derivados de acidos alcanoicos.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES520671A Granted ES520671A0 (es) 1981-06-18 1983-03-16 Un procedimiento para la preparacion de derivados de acidos alcanoicos.
ES520670A Expired ES8404307A1 (es) 1981-06-18 1983-03-16 Un procedimiento para la preparacion de derivados de acidos alcanoicos.

Country Status (23)

Country Link
US (1) US4513005A (es)
EP (1) EP0068739B1 (es)
KR (1) KR890000622B1 (es)
AU (1) AU549814B2 (es)
BG (1) BG37226A3 (es)
CA (1) CA1224795A (es)
CS (1) CS241109B2 (es)
DD (1) DD202697A5 (es)
DE (1) DE3261237D1 (es)
DK (1) DK271682A (es)
ES (3) ES8307212A1 (es)
FI (1) FI77847C (es)
GB (1) GB2101594B (es)
GR (1) GR76838B (es)
HU (1) HU192105B (es)
IE (1) IE53522B1 (es)
IL (1) IL66056A0 (es)
NZ (1) NZ200984A (es)
PH (1) PH23051A (es)
PL (4) PL240484A1 (es)
PT (1) PT75058B (es)
RO (1) RO83706B (es)
ZA (1) ZA824294B (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4537723A (en) * 1982-02-04 1985-08-27 The Upjohn Company Derivatives of leukotrienes A and C
US4775662A (en) * 1983-03-07 1988-10-04 Smithkline Beckman Corporation Leukotriene antagonists
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
US5017583A (en) * 1983-04-21 1991-05-21 Merck Frosst Canada, Inc. Leukotriene antagonists
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
EP0123543B1 (en) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotriene antagonists, their production and use and compositions containing them
US4720505A (en) * 1983-06-27 1988-01-19 Merck Frosst Canada, Inc. Leukotriene antagonists
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
AU572615B2 (en) 1983-12-27 1988-05-12 Sony Corporation Electrically conductive adhesive sheet circuit board and electrical connection structure
EP0147217A3 (en) * 1983-12-27 1986-08-13 Merck Frosst Canada Inc. Leukotriene antagonists
US4761425A (en) * 1983-12-27 1988-08-02 Merck Frosst Canada, Inc. Leukotriene antagonists
US4769386A (en) * 1984-06-18 1988-09-06 Smithkline Beckman Corporation Imidazolylthioalkenoic acids and -alkenols and leukotriene antagonistic composition containing them
US4649215A (en) * 1984-06-28 1987-03-10 Ciba-Geigy Corporation Aliphatic thioethers
US4889873A (en) * 1984-07-18 1989-12-26 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4758594A (en) * 1984-07-18 1988-07-19 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4988716A (en) * 1984-07-18 1991-01-29 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4798842A (en) * 1984-07-18 1989-01-17 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
ATE53991T1 (de) * 1985-04-19 1990-07-15 Smithkline Beecham Corp Leukotrien-antagonisten.
US4937253A (en) * 1985-04-19 1990-06-26 Smithkline Beecham Corporation Ester prodrugs
US4874792A (en) * 1985-04-19 1989-10-17 Smithkline Beckman Corporation Thiophenyl Alkanoic acids useful as leukotriene antagonists
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
US4990526A (en) * 1985-06-18 1991-02-05 Merck Frosst Canada, Inc. Leukotriene antagonists, compositions and methods of use thereof
US4696946A (en) * 1985-08-30 1987-09-29 Schering Corporation Topical Treatment of hyperproliferative skin diseases
US4783483A (en) * 1985-10-03 1988-11-08 Ortho Pharmaceutical Corporation Epoxides useful as antiallergic agents
US4808572A (en) * 1985-12-06 1989-02-28 Ciba-Geigy Corporation α-Hydroxy thioethers
KR870011086A (ko) * 1986-05-29 1987-12-19 벤자민 에프. 램버트 포스포리파제 a₂억제제 및 그의 합성방법
GB8709547D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Organic compounds
DE3724735A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten, sowie vorprodukte
DE3724669A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
AU610528B2 (en) * 1987-10-29 1991-05-23 Smithkline Beckman Corporation Leukotriene antagonists
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
US5073571A (en) * 1988-06-16 1991-12-17 Washington University Method of inhibiting virus
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
US5149835A (en) * 1989-04-27 1992-09-22 University Of New Mexico Substituted mevalonolactones, and methods for stereoselective preparation thereof and desmethyl homologues thereof
EP0410244A1 (en) * 1989-07-27 1991-01-30 Bayer Ag Leukotriene antagonists
US5238683A (en) * 1989-11-24 1993-08-24 The United States Of America As Represented By The Department Of Health And Human Services Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
AU7769491A (en) * 1990-05-01 1991-11-27 Smithkline Beecham Corporation 3-naphthyl-3-carboxyalkylthio or oxy substituted alkanoic acid leukotriene antagonists
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20030212191A1 (en) * 2002-04-15 2003-11-13 Nippon Bee Chemical Co., Ltd. Aqueous primer coating composition, process for formation of coating film using said composition, and coated article
WO2003099272A1 (en) * 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
WO2004046104A2 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US7964687B2 (en) * 2004-08-31 2011-06-21 Sumitomo Bakelite Company, Ltd. Oxylamino group-containing compound and polymer
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7754838B2 (en) * 2006-08-08 2010-07-13 E.I. Du Pont De Nemours And Company Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3177227A (en) * 1963-01-30 1965-04-06 Shell Oil Co Lactone production
DE2945497A1 (de) * 1979-03-06 1980-10-09 Degussa Derivate der d-2-hydroxy-4-methylmercaptobuttersaeure, verfahren zu deren herstellung und deren verwendung
US4311645A (en) * 1980-03-24 1982-01-19 Hoffmann-La Roche Inc. Synthesis of SRS-active compounds
FR2479213A1 (fr) * 1980-03-28 1981-10-02 Roussel Uclaf Procede de preparation d'acide pentenoique possedant une fonction aldehyde
JPS57118555A (en) * 1981-01-13 1982-07-23 Ono Pharmaceut Co Ltd Leucotriene-analog compound, its preparation, and leucotriene-biosynthesis inhibiting agent containing said compound as active component
US4352757A (en) * 1981-02-02 1982-10-05 Smithkline Beckman Corporation Process for the preparation of esters of leukotriene A

Also Published As

Publication number Publication date
PL137766B1 (en) 1986-07-31
GR76838B (es) 1984-09-04
RO83706B (ro) 1984-03-30
PL240482A1 (en) 1983-09-12
DE3261237D1 (en) 1984-12-20
KR890000622B1 (ko) 1989-03-22
ES8404322A1 (es) 1984-05-01
US4513005A (en) 1985-04-23
EP0068739A1 (en) 1983-01-05
ES513221A0 (es) 1983-07-01
ES520670A0 (es) 1984-05-01
IE821443L (en) 1982-12-18
ES520671A0 (es) 1984-05-01
IE53522B1 (en) 1988-12-07
FI77847C (fi) 1989-05-10
FI822205A0 (fi) 1982-06-18
DD202697A5 (de) 1983-09-28
CA1224795A (en) 1987-07-28
FI77847B (fi) 1989-01-31
BG37226A3 (en) 1985-04-15
HU192105B (en) 1987-05-28
PL236992A1 (en) 1983-08-15
IL66056A0 (en) 1982-09-30
NZ200984A (en) 1985-01-31
GB2101594A (en) 1983-01-19
DK271682A (da) 1982-12-19
PT75058B (en) 1985-07-26
PH23051A (en) 1989-03-10
ES8404307A1 (es) 1984-05-01
CS241109B2 (en) 1986-03-13
EP0068739B1 (en) 1984-11-14
AU549814B2 (en) 1986-02-13
CS456582A2 (en) 1985-07-16
GB2101594B (en) 1985-12-24
PL240484A1 (en) 1983-09-12
PT75058A (en) 1982-07-01
ZA824294B (en) 1983-06-29
KR840000483A (ko) 1984-02-22
AU8500882A (en) 1982-12-23
PL240483A1 (en) 1983-09-12
FI822205L (fi) 1982-12-19
RO83706A (ro) 1984-03-15

Similar Documents

Publication Publication Date Title
ES8404322A1 (es) Un procedimiento para la preparacion de derivados de acidos alcanoicos.
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
SE7407913L (es)
ES8104790A1 (es) Procedimiento para la preparacion de derivados de la glici- namida
ES8502129A1 (es) Un procedimiento para la preparacion de compuestos de acidos biliares
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
DK161146C (da) Analogifremgangsmaade til fremstilling af (2-halogenergolinyl)-n',n'-diethylurinstofderivater samt farmaceutisk acceptable syreadditionssalte heraf
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
SE8204918L (sv) Nya 3-amino-pregn-5-en-derivat, deras salter, sett for framstellning och anvendning derav som lekemedel och kompositioner innehallande dem
ES437541A1 (es) Procedimiento para la obtencion de composiciones formadoras de espuma.
ES8407066A1 (es) Derivados de 6 -metilprednisolona.
ES477562A1 (es) Procedimiento para preparar derivados de alcanolamina.
IL69036A (en) Alpha-alkyl undecapentaenoic acids,pharmaceutical compositions containing the same and processes for the preparation thereof
TW328948B (en) Composition and process for the synthesis of oxysulphide-containing fluorine-containing organic derivatives
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE10743T1 (de) Benzopyranylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel und zwischenprodukte.
SE7904543L (sv) Nya joniska bensen-polyjodidderivat for anvendning som kontrastmedel vid rontgenbehandling
ES2098370T3 (es) Derivado del acido epoxisuccinamico.
ATE26258T1 (de) Herstellung von phenylalaninen durch hydrierung von phenylserinen.
EP0069049A3 (en) Delta-8,9-prostaglandin derivatives, process for their preparation and their use as medicaments
ES8302715A1 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
MX163990B (es) Empleo de esteres parciales del acido citrico y sus mezclas para la extraccion del hierro
ES8103740A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
ES481603A1 (es) Un procedimiento para la preparacion de un derivado de la hidantoina.
ES8504187A1 (es) Procedimiento para la preparacion de nuevos derivados de acidos apovincaminicos racemicos y opticamente activos, y de sus sales de adicion acidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203